Thyroid Cancer

Smoking status added to the National Cancer Database for patients diagnosed with cancer in 2023 revealed variations in sociodemographic and socioeconomic factors, according to a research letter in JAMA Oncology.

Among adults with thyroid cancer, those with hypoparathyroidism after a thyroidectomy may have increased risk for several complications such as diabetes, hypertension and dyslipidemia, researchers reported.

Rather than tumor size alone, the American Thyroid Association’s risk stratification system should be used when assessing papillary thyroid microcarcinomas, according to data published in The Journal of Clinical Endocrinology & Metabolism.

After rising over a 35-year period, thyroid cancer incidence in the U.S. plateaued from 2010 to 2019, according to findings published in The Lancet Diabetes & Endocrinology.

Amycretin, a novel once-weekly subcutaneous GLP-1 and amylin receptor agonist, was safe compared with other incretin-based therapies and lead to significant weight loss in adults, according to top-line results from a phase 1b/2a trial.

Adults with type 2 diabetes using a GLP-1 drug have a similar risk for thyroid cancer as those using other diabetes drugs, though increased thyroid cancer risk was observed in the first year after GLP-1 initiation, researchers reported.

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, including measuring body fat to diagnose obesity instead of BMI alone.

Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a DPP-IV inhibitor, according to findings published in Thyroid.

Adults with low-risk thyroid cancer who underwent surgery had significant reductions in cancer-related fear and worry after their procedure compared with before surgery, researchers reported.

Suicide rates for individuals diagnosed with cancer increased over the past 2 decades, according to results of a retrospective study.